Company: BNBX
Filing Date: 2025-10-06
Form Type: 8-K
Source: 0001104659-25-097097
Chunk: 2

Company: BNB PLUS CORP.
Filing Date: 2025-10-06
Form: 8-K
Item: Item 9.01
Chunk 2
---
Item
9.01 Financial Statements and Exhibits.

(d) Exhibits.

  Exhibit No.      Description                                                                   
         99.1      Press Release, dated October 6, 2025.                                         
 ─────────────────────────────────────────────────────────────────────────────────────────────────
          104      Cover Page Interactive Data File (embedded within the Inline XBRL document).  

SIGNATURES

Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.

  Date: October 6, 2025      APPLIED DNA SCIENCES, INC.                               
 ──────────────────────────────────────────────────────────────────────────────────────
                             By:                             /s/ Beth Jantzen         
                             Name:                           Beth Jantzen             
                             Title:                          Chief Financial Officer